Performance vs S&P 500

03
Tracked Q4 2025–Q2 2026 -10.8%
S&P 500 total return (same window) +8.7%
Excess return -19.5%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

04
Consumer Discretionary 42.7%
Technology 29.9%
Healthcare 3.2%
Other/Unmapped 24.2%

Full portfolio 5 positions

05
Type Streak 8Q trend
NAVN Navan, Inc. - Class A Common Stock $163,263,647 42.74% 7,138,769 $68,746,345
Unknown issuer (CUSIP: 84615Q103) $92,353,247 24.18% 540,520 Up ×1
FIG Figma, Inc. Class A Common Stock $73,354,733 19.20% 4,054,988 $-12,367,713
IOT Samsara Inc. Class A Common Stock $40,730,264 10.66% 1,255,944 $929,399
BIOA BioAge Labs, Inc. - Common Stock $12,299,927 3.22% 501,833 $3,522,868

Biggest new bets

09

New positions opened this quarter, largest first.

SecurityValueShares% of portfolio
Unknown issuer (CUSIP: 84615Q103) $92,353,247 540,520 24.18%

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
NAVN Price move only +0 +$68.7M
FIG Price move only +0 -$12.4M
BIOA Price move only +0 +$3.5M
IOT Price move only +0 +$929K